Выбор редакции

Nice decision on prostate cancer drug is a 'kick in the teeth' for patients

Charity and scientists criticise drug approval body for not offering abiraterone to sufferers until after they had chemotherapy

The decision not to offer a life-extending drug to prostate cancer sufferers until after they have received chemotherapy is a "kick in the teeth" for patients, a charity has said.

Prostate Cancer UK said that the drug could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.

Continue reading...